Factors Associated With Willingness to Receive a COVID-19 Vaccine Among 23,819 Adults Aged 50 Years or Older: An Analysis of the Canadian Longitudinal Study on Aging.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
20 05 2022
Historique:
received: 23 05 2021
revised: 01 02 2022
accepted: 03 02 2022
pubmed: 16 2 2022
medline: 9 6 2022
entrez: 15 2 2022
Statut: ppublish

Résumé

Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50-96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.

Identifiants

pubmed: 35166332
pii: 6528789
doi: 10.1093/aje/kwac029
pmc: PMC8903402
doi:

Substances chimiques

COVID-19 Vaccines 0
Influenza Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

987-998

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.

Références

Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):
pubmed: 33632802
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Can J Aging. 2015 Sep;34(3):366-77
pubmed: 26300192
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):
pubmed: 33731429
Lancet. 2021 Mar 13;397(10278):1023-1034
pubmed: 33587887
Can Commun Dis Rep. 2016 Dec 01;42(12):246-251
pubmed: 29769995
Eur J Epidemiol. 2020 Dec;35(12):1123-1138
pubmed: 33289900
Vaccine. 2014 Apr 1;32(16):1841-7
pubmed: 24530926
PLoS One. 2021 May 24;16(5):e0251963
pubmed: 34029345
BMC Infect Dis. 2021 Apr 12;21(1):338
pubmed: 33845781
Int J Epidemiol. 2019 Dec 1;48(6):1752-1753j
pubmed: 31633757
Clin Neuropsychol. 2017 Jan;31(1):233-250
pubmed: 27830627
BMC Public Health. 2019 Feb 28;19(1):243
pubmed: 30819126
Vaccine. 2018 Jun 27;36(28):4118-4125
pubmed: 29789242

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH